U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07235397) titled 'Evaluating the Benefits of RSV Maternal Vaccination Using a Scottish National Dataset' on Nov. 14.
Brief Summary: This study will use a retrospective cohort design and will be conducted within routinely collected national healthcare and statutory demographic datasets held by PHS and National Records of Scotland (NRS). As such, there will be no active enrollment of study participants, no direct contact with study participants, no collection of any primary data outside of the standard of care (SOC), and no requirement for informed consent.
This study design was chosen due to several advantages, over other possible designs, including ...